PAI-1 is also a well-recognized acute phase protein and there is emerging evidence regarding its central role in COVID-19-associated endothelial dysfunction, supporting PAI-1 as a potential mechanistic link between known risk factors (e.g., tobacco use, age) and clinical manifestations of COVID-19 [50]. The gene discussed is SERPINE1; the disease is endothelial dysfunction.